• Pacira BioSciences CFO Shawn Cross sold 12,059 shares in transactions dated April 20-22.
• Sales were priced at USD 25.14 per share on April 20, USD 25.01 per share on April 21-22.
• Cross exercised stock options for 12,059 shares at USD 16.45 per share over same period.
• Directly held common stock position was 105,341 shares following transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-026669), on April 22, 2026, and is solely responsible for the information contained therein.